1 | indications | 5,541 |
2 | indication | 3,715 |
3 | explanation | 1,223 |
4 | possibilities | 736 |
5 | argument | 349 |
6 | outlook | 146 |
7 | antidote | 79 |
8 | evidence-base | 76 |
9 | excuse | 19 |
10 | obstetrician/gynecologist | 14 |
11 | dnazymes | 10 |
12 | benefix | 9 |
13 | immunologist | 7 |
14 | inducements | 7 |
15 | seropositivities | 7 |
16 | ethno-medicine | 6 |
17 | flexibilities | 6 |
18 | keystones | 5 |
19 | neutraceutical | 5 |
20 | 'criteria | 4 |
21 | immunomarker | 4 |
22 | semiotics | 4 |
23 | skillsets | 4 |
24 | stratagem | 4 |
25 | e-application | 3 |
26 | exo-site | 3 |
27 | triviality | 3 |
28 | acanthocephalan | 2 |
29 | co-selection | 2 |
30 | dose-adjustments | 2 |
31 | dp- | 2 |
32 | erratum | 2 |
33 | immuno-assays | 2 |
34 | invega | 2 |
35 | mileu | 2 |
36 | ten-structure | 2 |
37 | viibryd | 2 |
38 | adjuvance | 1 |
39 | dendrite-depolarizing | 1 |
40 | di16:0-pa | 1 |
41 | distress.implications | 1 |
42 | joke-dangers | 1 |
43 | limited-progress | 1 |
44 | mi/cbt | 1 |
45 | mild-natured | 1 |
46 | nexterone | 1 |
47 | nondiscogenic | 1 |
48 | ph-treatments | 1 |
49 | schedule/formulation | 1 |
50 | sudoscan | 1 |
51 | suroundings | 1 |
52 | test/examination | 1 |
53 | trait-markers | 1 |
54 | volume-relationship | 1 |
55 | warm-natured | 1 |
1 | 'criteria | 4 |
2 | acanthocephalan | 2 |
3 | adjuvance | 1 |
4 | antidote | 79 |
5 | argument | 349 |
6 | benefix | 9 |
7 | co-selection | 2 |
8 | dendrite-depolarizing | 1 |
9 | di16:0-pa | 1 |
10 | distress.implications | 1 |
11 | dnazymes | 10 |
12 | dose-adjustments | 2 |
13 | dp- | 2 |
14 | e-application | 3 |
15 | erratum | 2 |
16 | ethno-medicine | 6 |
17 | evidence-base | 76 |
18 | excuse | 19 |
19 | exo-site | 3 |
20 | explanation | 1,223 |
21 | flexibilities | 6 |
22 | immuno-assays | 2 |
23 | immunologist | 7 |
24 | immunomarker | 4 |
25 | indication | 3,715 |
26 | indications | 5,541 |
27 | inducements | 7 |
28 | invega | 2 |
29 | joke-dangers | 1 |
30 | keystones | 5 |
31 | limited-progress | 1 |
32 | mi/cbt | 1 |
33 | mild-natured | 1 |
34 | mileu | 2 |
35 | neutraceutical | 5 |
36 | nexterone | 1 |
37 | nondiscogenic | 1 |
38 | obstetrician/gynecologist | 14 |
39 | outlook | 146 |
40 | ph-treatments | 1 |
41 | possibilities | 736 |
42 | schedule/formulation | 1 |
43 | semiotics | 4 |
44 | seropositivities | 7 |
45 | skillsets | 4 |
46 | stratagem | 4 |
47 | sudoscan | 1 |
48 | suroundings | 1 |
49 | ten-structure | 2 |
50 | test/examination | 1 |
51 | trait-markers | 1 |
52 | triviality | 3 |
53 | viibryd | 2 |
54 | volume-relationship | 1 |
55 | warm-natured | 1 |
1 | dp- | 2 |
2 | invega | 2 |
3 | 'criteria | 4 |
4 | di16:0-pa | 1 |
5 | nondiscogenic | 1 |
6 | mild-natured | 1 |
7 | warm-natured | 1 |
8 | viibryd | 2 |
9 | adjuvance | 1 |
10 | ethno-medicine | 6 |
11 | nexterone | 1 |
12 | ten-structure | 2 |
13 | evidence-base | 76 |
14 | excuse | 19 |
15 | exo-site | 3 |
16 | antidote | 79 |
17 | dendrite-depolarizing | 1 |
18 | outlook | 146 |
19 | neutraceutical | 5 |
20 | stratagem | 4 |
21 | erratum | 2 |
22 | sudoscan | 1 |
23 | acanthocephalan | 2 |
24 | indication | 3,715 |
25 | e-application | 3 |
26 | schedule/formulation | 1 |
27 | explanation | 1,223 |
28 | test/examination | 1 |
29 | co-selection | 2 |
30 | volume-relationship | 1 |
31 | immunomarker | 4 |
32 | semiotics | 4 |
33 | possibilities | 736 |
34 | flexibilities | 6 |
35 | seropositivities | 7 |
36 | dnazymes | 10 |
37 | keystones | 5 |
38 | suroundings | 1 |
39 | indications | 5,541 |
40 | distress.implications | 1 |
41 | joke-dangers | 1 |
42 | trait-markers | 1 |
43 | limited-progress | 1 |
44 | skillsets | 4 |
45 | inducements | 7 |
46 | ph-treatments | 1 |
47 | dose-adjustments | 2 |
48 | immuno-assays | 2 |
49 | mi/cbt | 1 |
50 | argument | 349 |
51 | obstetrician/gynecologist | 14 |
52 | immunologist | 7 |
53 | mileu | 2 |
54 | benefix | 9 |
55 | triviality | 3 |